No Guarantee of Treatment Outcomes: Weight loss results with GLP-1 medications, whether oral or injectable, compounded or branded, vary significantly between individuals based on numerous factors including starting weight, metabolic health status, genetic factors, lifestyle habits, medication adherence, diet quality, physical activity levels, sleep patterns, stress management, underlying medical conditions, concurrent medications, and other variables
#PharmaNews #HealthcareInnovation #PharmaStrategy #IndianPharma #PharmaUpdates #Harshal #PharmawithHJ #HJ To view or add a comment, sign in Exploring the Complexities of GLP-1 Drugs GLP-1 receptor agonists like Ozempic, Wegovy, and Mounjaro are revolutionizing diabetes and obesity treatment
Al-Aly emphasizes that the risk reduction is modest, but in the absence of a proven effective treatment, this is definitely welcome news and a big deal, and one that researchers will continue to study
Inaishi J, Saisho Y (2022) Exenatide once weekly for management of type 2 diabetes: a review
Key Strategies to Help Reduce Your Risk of Weight Gain After Stopping Mounjaro Healthy and Balanced Eating Habits Focus on maintaining the portion control you learned while on Mounjaro
More ways to help your patients with T2D Check your patients' coverage and view savings offer Ozempic is available in 3 doses for more A1C control is available in 3 doses for more A1C control CV=cardiovascular
